title: TB control: challenges and opportunities for India.
abstract: India's TB control programme has treated over 19 million patients, but the incidence of TB continues to be high. TB is a major killer and drug-resistant TB is a growing threat. There are several likely reasons, including social conditions and co-morbidities that fuel the TB epidemic: under-investment by the government, weak programme implementation and management, suboptimal quality of care in the private sector, and insufficient advocacy around TB. Fortunately, India possesses the technical know-how, competence and resources to address these challenges. The End TB Strategy by WHO offers India an excellent blueprint to advance the agenda of TB control.
authors.affiliation: McGill International TB Centre, McGill University, Montreal, Canada madhukar.pai@mcgill.ca.
authors.forename: Madhukar
authors.initials: M
authors.lastname: Pai
authors.affiliation: McGill International TB Centre, McGill University, Montreal, Canada.
authors.forename: Amrita
authors.initials: A
authors.lastname: Daftary
authors.affiliation: McGill International TB Centre, McGill University, Montreal, Canada.
authors.forename: Srinath
authors.initials: S
authors.lastname: Satyanarayana
mesh_terms: D000995:Antitubercular Agents / Q000627:therapeutic use; D003695:Delivery of Health Care / Q000458:organization & administration*; D060740:Disease Eradication / Q000458:organization & administration*; D006297:Health Services Accessibility / Q000458:organization & administration; D006801:Humans; D015994:Incidence; D007194:India / Q000453:epidemiology; D014397:Tuberculosis, Pulmonary / Q000453:epidemiology / Q000517:prevention & control*; D014944:World Health Organization
chemical_list: D000995:Antitubercular Agents
keywords: India; TB control; Tuberculosis